Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

625
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
625
Randomized Experiments01:13

Randomized Experiments

6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.3K
Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Hazard Ratio01:12

Hazard Ratio

750
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
750
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

353
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
353

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.

BMJ (Clinical research ed.)·2026
Same author

AI-enabled GRADE: How the GRADE Working Group will use automation to rate the certainty of evidence of intervention effects.

Journal of clinical epidemiology·2026
Same author

In acute hypoxemic respiratory failure, high-flow vs. standard oxygen therapy did not reduce mortality at 28 d.

Annals of internal medicine·2026
Same author

Detrimental effects of conflicts of interest in GLP-1 therapy guidance.

BMJ (Clinical research ed.)·2026
Same author

Reply to the Letter to the Editor re: Antibiotic Use in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter Retrospective Cohort Study.

Journal of general internal medicine·2026
Same author

Barriers and Facilitators to Interest-Holder Engagement in Health Guideline Development: A Qualitative Evidence Synthesis.

Campbell systematic reviews·2026

関連する実験動画

Updated: Apr 24, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

ランダム化臨床試験データの再分析

Shanil Ebrahim1, Zahra N Sohani2, Luis Montoya3

  • 1Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California2Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada3Department of Anesthesia, McMaster University4Depa.

JAMA
|September 10, 2014
PubMed
まとめ

ランダム化臨床試験 (RCT) の再分析は稀で,独立したものはほとんどない. 多くの再分析は結果を変え,患者の治療勧告に影響を与えます.

さらに関連する動画

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

関連する実験動画

Last Updated: Apr 24, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

科学分野:

  • 医学研究方法論 医学研究方法論
  • 臨床試験分析 臨床試験分析について
  • エビデンス・シンセシス

背景:

  • ランダム化臨床試験 (RCT) データの再分析は,報告された結果の検証に不可欠です.
  • 試験結果の妥当性を評価することで,科学界の信頼とデータの完全性を高めることができます.

研究 の 目的:

  • RCTデータに関する公表された再分析を特定し,特徴づけること.
  • 患者の治療に関する著者の独立性と解釈の変化を評価する.
  • 臨床的結論に対する再分析の影響を理解する.

主な方法:

  • RCTの再分析のためのMEDLINEの体系的な電子検索.
  • 4人の専門家による独立したデータ抽出.
  • オリジナルRCTの比較と,その再分析が公表された比較.

主要な成果:

  • 36の出版物で37の適格な再分析が特定されました.
  • 再分析は,統計的方法 (18) と結果の定義 (12) で一般的に異なっていた.
  • 13回の再分析 (35%) の結果,患者の治療勧告の解釈が変更された.

結論:

  • 公開されたRCT再分析は稀であり,独立した実行は限られている.
  • 再分析の有意な割合は,患者の治療選択に関する修正された結論につながる.
  • 再分析は,臨床研究におけるデータの透明性と独立した検証の重要性を強調しています.